Skip to search formSkip to main contentSkip to account menu

Aggrastat

Known as: Merck Frosst brand of tirofiban hydrochloride monohydrate, Agrastat, Cahill May Roberts brand of tirofiban hydrochloride monohydrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This study aims to investigate the short-term efficacy and safety of intracoronary tirofiban administration during emergency… 
2014
2012
2012
Background:­ In this article, we aimed to investigate the effects of antithrombotic agents, including acetyl salicylic acid (ASA… 
2009
2009
AIM To evaluate the efficacy and safety of intracoronary tirofiban on TIMI flow in acute coronary syndrome (ACS) with noreflow… 
2007
2007
Objective To study the effect and safety of tirofiban hydrochlorid in patients with acute coronary syndromes (ACS) during their… 
2006
2006
Glycoprotein IIb/IIIa inhibitor therapy during primary percutaneous coronary intervention (PCI) decreases the incidence of major… 
2003
2003
Acute peripheral arterial occlusive disease is an important factor affecting the mobility and mortality rate of elderly patients… 
Review
2001
Review
2001
Therapy involving the use of anti-GPIIb-IIIa inhibitors has progressively evolved in recent years for patients undergoing…